-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 391M shares, a 44.8% increase year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 270M shares, a 88.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)